You are here: Home / About Us / Medical Team / Dr. Xiaodong Wang, MD, PhD

Dr. Xiaodong Wang, MD, PhD


Dr. Wang is currently the Deputy Director of the Stem Cell Transplantation Department. She also serves as a physician with extensive experience in neurology and pediatrics.

Between 2006 and 2008 she received the highest level national public scholarship to pursue postdoctoral degree in research at Harvard University and the University of Rochester, in the USA. Her postdoctoral research focus was neural stem cells in central nervous system (CNS) injury and repair involving molecular mechanisms.

Dr. Wang is a recipient of many honors and awards including the Science & Technology Progress Awards awarded by the Ministry of Health and the Armed Police Force Science and Technology Progress Award.

She is respected by her clients for her warm-hearted and compassionate approach in treating children and infants.

Board Certified:

Pediatrics and Neurology

Medical Education

  • Post-doctorate, Harvard University; Rochester Medical Center (2006–2008)
  • Peking University, Oncology Center (2000–2003)
  • Pediatric neurology MSc, Beijing Medical University; Beijing Hospital (1992–1995)
  • Pediatrics BSc, Suzhou Medical College (1979–1984)

Medical Employment

  • Deputy Director, General Hospital of Chinese People’s Armed Police Forces, Neural Stem Cell Transplantation Dept. (2008–present)
  • Pediatric attending physician, Deputy Chief Physician, General Hospital of Chinese People’s Armed Police Forces, Dept. of Pediatrics (1995–2008)
  • Pediatrician, Women and Children’s Hospital of Peking University (1990–1995)
  • Pediatrician, Affiliated Hospital of Hebei Medical University (1984–1990)

Research Papers

  • Bone marrow-derived mesenchymal stem cells and lateral hepatocyte differentiation. Chinese Clinical Rehabilitation 2006; 10(45): 121–124.
  • Dendritic cells for immune therapy of primary liver cancer and the potential of cross-cutting research on bone marrow stem cell differentiation. Modern Oncology. 2005; 4: 56–70.
  • VX2 number of living cells with rabbit liver cancer model of success rate and time into the relationship between tumor. Modern Oncology. 2005; 4: 25–28.
  • Mesenchymal stem cells modulate differentiation in hepatocytes in VX2 implanted rabbit liver cancer. Blood 2005; 106: 4303.
  • Pharmacokinetic and pharmacodynamic effects of clonazepam in children with epilepsy treated with valproate: a preliminary study. Ther Drug Monit 2002 Aug; 24(4): 532–6.